This study aims to investigate the utility of predictive models for chemotherapy-induced nephrotoxicity in the Taiwanese cancer population. The investigators will prospectively collect clinical data from enrolled participants, including demographic information, comorbidities, laboratory data, and chemotherapy treatment details. After chemotherapy administration, participants' renal function will be monitored over time to assess the development of nephrotoxicity, based on changes in serum creatinine (SCr) and other relevant clinical criteria. The primary objective is to evaluate and compare the predictive performance of a machine learning model and clinical physicians, using the area under the receiver operating characteristic curve (AUROC) as the main metric for discrimination performance.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
AUROC comparison
Timeframe: 89 days